Test for the Tripledemic. Three Infections: One Test.

Ethos offers an all-in-one COVID-19, Influenza A&B, and RSV test. Experience the next level of diagnostic precision with our state-of-the-art multiplexed real-time PCR solution.

Questions? Email sales@ethos-labs.com for more information. Ready to get started? Click here to order supplies and initiate the start-up process.

A computer generated image of a corona virus cell Infectious Disease Intelligence Logo

Enhanced Target Coverage

With multiple gene targets for SARS-CoV-2, Influenza A, Influenza B, and RSV, our solution offers heightened result confidence. Additionally, it adapts seamlessly to emerging mutations and variants, providing a forward-looking approach to diagnostic testing.

Rapid Results

Receive conclusive results within 24 hours from the moment your sample reaches the laboratory, providing swift insights for timely decision making.

Extended Sample Stability

Our solution guarantees sample stability for up to 5 days after collection at room temperature, allowing for convenient and flexible transportation.

Collection Integrity Assurance

The inclusion of an RNase P internal control confirms proper sample collection, ensuring the integrity of the gathered specimens.

Comprehensive Confirmation

Validated with both nasopharyngeal and anterior nasal swabs to ensure accuracy and reliability in diverse sample types.

Time-Saving Reports

We developed the Ethos Snapshotâ„¢ from healthcare provider feedback. The report offers healthcare providers with a clear and concise summary of the test results in an easy-to-read format.

Delivering Intelligence to Inform Decisions


Differentiate SARS-CoV-2 (COVID-19), Influenza A + B, RSV


Validated with both nasopharyngeal and anterior nasal swabs


Results are accessible within 24 hours from the moment the laboratory receives the sample.